Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early-to-late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, Vaniqa and Natroba. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. Its Natroba (spinosad) Topical Suspension is indicated for the topical treatment of head lice and scabies infestations in adult and pediatric patients.


TSX:CPH - Post by User

User Avatar Image
(6)
•••
  • DrewJacksonX
Comment by DrewJacksonon Nov 09, 2022 12:52pm
226 Views
Post# 35085744

RE:Tomorrrow the wait will be over....

RE:Tomorrrow the wait will be over....

It's available on https://www.sedi.ca/

The System for Electronic Disclosure by Insiders (SEDI) is Canada's website for filing and viewing insider trades. SEDI is old and clunky, just like The System for Electronic Document Analysis and Retrieval (SEDAR). SEDAR is the system for Canadian Securities Companies to file their press releases, quarterly reports, and annual reports. 

Back to your original comment: Cipher was buying back around 140,000 shares per month on average on the last NCIB. They drastically reduced that to 39,317 shares bought back in September. They usually file on the 11th, so we won't know how many shares they bought back for October until around November 11th. The reduction in buybacks is probably because they want to conserve cash in anticipation of an acquisition.

 

<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities